| Accession Number: | 0001516551-23-000091 |
| Date: | 2023-11-06 |
| Issuer: | SKYE BIOSCIENCE, INC. (SKYE) |
| Original Submission Date: |
SCHWAB ANDREW J.
C/O 5AM VENTURE MANAGEMENT, LLC
501 SECOND STREET, SUITE 350
SAN FRANCISCO, CA 94107
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 3.5 | 2023-11-06 | deemed execution date | A | 14,110 (a) | 2033-08-25 | common stock 14,110 | $3.50 | 20,001 | direct |
| ID | footnote |
|---|---|
| f1 | the option grant shall be exercisable for a price of $3.50 per option share for ten years from august 25, 2023 and the options will vest in equal monthly installments over the one year period beginning august 24, 2023. |
